The Gen Re Perspective

Stay Up to Date. Subscribe Today.




Publication Series

    Life/Health International(34)

    Life/Health North America(3)

Nine Questions Mutual Company Directors Should Ask When Assessing Their ERM Culture

Every year our Mutual Practice team looks forward to the National Association of Mutual Insurance Companies (NAMIC) Annual Convention. With nearly 2,000 attendees, it is a great opportunity to experience the rich tradition of the mutual insurance industry, enjoy a diverse a range of talented keynote speakers and listen to a multitude of stimulating panel discussions.

  • Genetics and Insurance - One Perspective on Future Directions

    By Dr. John Chevers, PHG Foundation, Cambridge, UK (guest contributor) | Mar 15, 2018 | English

    Insurers understand better than most that predicting ill health is more about probability than certainty. The industry’s predictive expertise is developed from objective analysis of medical reports and claim histories. Underwriters never have definitive...

    Read More
  • Assessing Elderly Heart Disease Risk

    By Dr. John O'Brien | Mar 08, 2018 | English

    The prevalence of cardiovascular disease - hypertension, coronary heart disease, heart failure or stroke - increases with age. Often, multiple cardiac conditions coexist with other illnesses, and this makes risk assessments for applicants aged 70 and...

    Read More
  • Care and Attention Needed When Developing an LTC Portfolio

    By Sabrina Link and Annika Tiedemann | Feb 20, 2018 | English

    Long Term Care (LTC) insurance is a complex product that’s challenging for carriers on both the product and underwriting side. It’s hard to find a model example in a particular market because countries have their own social frameworks and LTC insurance...

    Read More
  • A Blood Test Can’t Detect Cancer, Can It?

    By Andres Webersinke | Feb 06, 2018 | English

    We began 2018 with some promising news on cancer: A simple blood test can now detect disease in eight common sites. Called the CancerSEEK test, it was developed at the Johns Hopkins Kimmel Cancer Center, and may herald a new age in cancer medicine. How...

    Read More